BioSpace News Archive

Year

• 2005
• 2006
• 2007
• 2008
• 2009
• 2010
• 2011
• 2012
• 2013
• 2014
• 2015
• 2016
• 2017
• 2018
• 2019
• 2020
• 2021
• 2022
• 2023
• 2024
• 2025

Month

• January
• February
• March
• April
• May
• June
• July
• August
• September
• October
• November
• December

Day

• 1
• 2
• 3
• 4
• 5
• 6
• 7
• 8
• 9
• 10
• 11
• 12
• 13
• 14
• 15
• 16
• 17
• 19
• 20
• 21
• 22
• 23
• 24
• 26
• 27
• 28
• 29
• 30

• BioCapital

  Diffusion Pharmaceuticals Regains Compliance with Nasdaq Capital Market Minimum Equity Rule

  The Company today announced that it has received notice from Nasdaq stating that the Company complies with the Nasdaq Capital Market Listing Rules requiring minimum stockholders’ equity of $2.5 million.

  November 20, 2017

   · 

  4 min read
• Business

  Neurocrine Biosciences Appoints Matt Abernethy as CFO

  Abernethy has nearly 15 years of experience in the financial sector and investor relations with expertise in the healthcare industry.

  November 20, 2017

   · 

  4 min read
• 

  Drug Development

  Genentech Shows Off Positive Results From Phase III HEMLIBRA, TECENTRIQ Studies

  Data will be submitted to health authorities globally, including the FDA and EMA.

  November 20, 2017

   · 

  17 min read
• Business

  Biohaven Receives Agreement From FDA on Initial Pediatric Study Plan for Rimegepant, a Second Generation Oral CGRP-Receptor Antagonist for the Acute Treatment of Migraine

  Agreement on an iPSP is one of the regulatory requirements that must be met prior to submitting a NDA.

  November 20, 2017

   · 

  4 min read
• Drug Development

  Chugai’s Bispecific Antibody Emicizumab Meets Primary Endpoint in Phase lll Study

  No thrombotic events occurred in this study.

  November 20, 2017

   · 

  6 min read
• 

  Deals

  LivaNova Sells Its Cardiac Rhythm Management Biz to MicroPort for $190M Cash

  The CRM Business Franchise develops, manufactures and markets products for the diagnosis, treatment and management of heart rhythm disorders and heart failures.

  November 20, 2017

   · 

  11 min read
• Business

  DiA Imaging Analysis Enters Partnership With GE Healthcare on Automatic Imaging Analysis Tools

  DiA Imaging Analysis, a medical imaging analysis software company, today announced that it has signed a multi-year, non-exclusive licensing and professional services agreement with GE Healthcare.

  November 20, 2017

   · 

  2 min read
• 

  Business

  Gamida Cell Taps Former Clal Biotech CSO as New Leader

  Dr. Adams to further advance promising pipeline, including breakthrough therapy, NiCord, in phase 3 development as a universal bone marrow transplant solution.

  November 20, 2017

   · 

  3 min read
• Business

  PathoQuest Announces Formation of Scientific Advisory Board

  Members of the Scientific Advisory Board are recognized infectious diseases, microbiology and next-generation sequencing experts.

  November 20, 2017

   · 

  3 min read
• Business

  Circle Pharma Announces Appointment of David Spellmeyer, PhD, as Chief Scientific Officer

  Dr. Spellmeyer brings over 25 years of broad industrial experience to Circle. He previously served as CTO & CIO at Nodality,

  November 20, 2017

   · 

  3 min read